Related Experiment Video
Updated: Jul 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report
Yan Li1, Ya-Qin Tan, Zhi-Xiang Tang
1Department of Endocrinology and Metabolism, Longgang District People's Hospital of Shenzhen, The Third Affiliated Hospital (Provisional) of The Chinese University of Hong Kong, Longgang central city, Shenzhen, Guangdong, P.R. China.
Rationale:
Multiple endocrine neoplasia 2A (MEN2A) is a rare autosomal-dominant genetic syndrome, frequently misdiagnosed or neglected clinically, resulting in delayed therapy to patients.
Patient Concerns:
A 47-year-old Chinese male patient underwent laparoscopic right adrenal tumorectomy, and postoperative pathology confirmed the tumor as pheochromocytoma (PHEO). He was readmitted to the department of endocrinology and metabolism due to constant increase in carcinoembryonic antigen (CEA) at 5 months after the operation.
Diagnosis:
The patient was confirmed with medullary thyroid carcinoma (MTC), multiple neck lymph node metastasis, and pituitary microadenoma. The p.Cys611Tyr (c.1832G>A, C611Y) mutation was detected. Therefore, he was diagnosed with MEN2A.
Interventions:
He underwent total thyroidectomy. The gene-sequencing analysis of his family was conducted, and the C611Y mutation was detected in his daughter.
Outcomes:
The level of carcinoembryonic antigen decreased significantly after thyroidectomy in this patient. Long-term follow-up management was conducted. Elevated serum calcitonin and bilateral thyroid nodules were found in his 13-year-old daughter. Thus, MEN2A was highly suspected and she was suggested to undergo total thyroidectomy.
Conclusion:
Patients with MEN2A should be screened regularly and managed by a multidisciplinary team.
Insights
Multiple endocrine neoplasia 2A (MEN2A) is a rare genetic disorder. Early diagnosis and multidisciplinary management are crucial for patients with MEN2A, as demonstrated by this case involving pheochromocytoma and medullary thyroid carcinoma.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple Endocrine Neoplasia 2A (MEN2A) is a rare autosomal-dominant disorder.
- Clinical underdiagnosis of MEN2A can lead to delayed treatment.
Observation:
- A 47-year-old male with pheochromocytoma (PHEO) developed elevated carcinoembryonic antigen (CEA) post-surgery.
- Further evaluation revealed medullary thyroid carcinoma (MTC), neck lymph node metastasis, and pituitary microadenoma.
Findings:
- Genetic analysis identified the p.Cys611Tyr (C611Y) mutation, confirming MEN2A diagnosis.
- The patient underwent total thyroidectomy, leading to a significant decrease in CEA levels.
- His daughter, also carrying the C611Y mutation, presented with elevated calcitonin and thyroid nodules, prompting a recommendation for thyroidectomy.
Implications:
- Regular screening and comprehensive management by a multidisciplinary team are essential for MEN2A patients.
- Genetic testing and family screening are critical for early detection and intervention in MEN2A kindreds.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Abnormal Proliferation
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...